NCT03938766View on ClinicalTrials.gov

Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PSMA PET/CT

Repeat PSMA PET/CT 4 weeks post initiation of clinically indicated ADT in patients with prior negative PSMA PET/CT performed for biochemical recurrence.

Trial Locations (1)

H4R3E8

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT03938766 - Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate Cancer | Biotech Hunter | Biotech Hunter